RxDoctor Payments Data

John Otis, MD

Psychiatry · la Jolla, CANPI 1235154535

Payments from drug & device makers

$988in general payments, 2019–2025

Across 46 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$296
  • Vanda Pharmaceuticals Inc.$290
  • Otsuka America Pharmaceutical, Inc.$92
  • Johnson & Johnson$66
  • Lundbeck LLC$65
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$63
  • plus $117 from 4 others

What the payments were for

  • Food & beverage$988100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$988 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$125,023
Medicare patients
237
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate65$224,282
Aripiprazole306$52,526
Chlorpromazine Hcl87$30,109
Olanzapine508$12,446
Quetiapine Fumarate499$11,336
Clozapine OdtClozapine12$10,713
Clozapine106$8,472
Trazodone Hcl488$5,502
Divalproex Sodium229$5,404
Desmopressin Acetate36$5,063
Oxcarbazepine162$5,003
Divalproex Sodium ErDivalproex Sodium47$3,709
Paliperidone ErPaliperidone16$3,677
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate12$3,134
Fluphenazine Decanoate25$3,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$66$224,28265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →